Holmium laser enucleation of the prostate (HoLEP) is a size independent option for benign prostatic hyperplasia (BPH) surgical management. Since lower urinary tract symptoms (LUTS) are a quality-of-life issue, studies should prioritize patient reported outcomes (PROs).
This HoLEP review assesses PROs inclusion in the top 20 cited HoLEP studies and defines their limitations. PROs were categorized by domain: LUTS, incontinence, sexual function, pain, hematuria, and patient satisfaction. On review, no top cited study included all PRO domains. The nuanced patient experience after HoLEP could be better defined via standardized utilization of validated PROs, while also improving comparability between HoLEP studies.
Urology. 2024 Mar 03 [Epub ahead of print]
Laena Hines, Kaela Mali, Timothy Campbell, Rajat Jain, Scott O Quarrier
Department of Urology, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: ., University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Department of Urology, University of Rochester Medical Center, Rochester, NY, USA.
PubMed http://www.ncbi.nlm.nih.gov/pubmed/38442790